Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 7, 2017; 23(25): 4579-4586
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4579
Published online Jul 7, 2017. doi: 10.3748/wjg.v23.i25.4579
Initial conservative, n = 13 | Initial intervention, n = 10 | Total, n = 23 | P value | |
Median age (yr) | 36 (30.5-43.5) | 33.5 (23.5-48.0) | 34 (30-44) | 0.563 |
Median HCA diameter at diagnosis (mm) | 76 (55-101.5) | 76.5 (51.3-92.5) | 76 (55-92) | 0.648 |
Median follow-up time (mo) | 66 (23-87) | 22.5 (12.8-60.3) | 36 (15-79) | 0.257 |
Type of bleeding | 0.349 | |||
Grade II | 9 | 5 | 15 | |
Grade III | 4 | 5 | 8 | |
Median hospital stay (d) | 13 (8.5-19) | 18 (10-33) | 13 (9.3-21.3) | 0.588 |
Median Hb level at presentation (mmol/L) | 8.0 (6.0-8.4) | 7.5 (7.0-8.0) | 7.6 (7.0-8.1) | 0.710 |
Median decrease Hb day 0-3 (mmol/L) | 0.9 (0-1.7) | 2.4 (1.6-3.5) | 1.6 (0.4-2.4) | 0.0061 |
- Citation: Klompenhouwer AJ, de Man RA, Thomeer MG, Ijzermans JN. Management and outcome of hepatocellular adenoma with massive bleeding at presentation. World J Gastroenterol 2017; 23(25): 4579-4586
- URL: https://www.wjgnet.com/1007-9327/full/v23/i25/4579.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i25.4579